Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study

Table 1 Clinical characteristics in 46 patients with cardiomyopathy

	Infiltrative cardiomyopathy (n = 11)	HCM (n = 35)	p value
Age*, years	68 ± 11	57 ± 16	0.015
Gender: men, n (%)	8 (73 %)	16 (46 %)	0.118
Hs-cTnT*, ng/ml	0.083 ± 0.057	0.027 ± 0.034	<0.001
BNP*, pg/ml	349 ± 341	288 ± 378	0.322
eGFR, ml/min per 1.73 m²	61 ± 17	73 ± 21	0.090
NYHA functional class, n (%)			0.071
I	2 (18 %)	20 (57 %)
II	8 (73 %)	14 (40 %)
III	1 (9 %)	1 (3 %)
Hx. of heart failure admission, n (%)	5 (45 %)	6 (17 %)	0.100
Atrial fibrillation, n (%)	1 (9 %)	4 (11 %)	1.00

Data are shown as mean ± SD or number (percent)
A mark of * is the results of Wilcoxon rank sum test
HCM hypertrophic cardiomyopathy, Hs-cTnT High-sensitivity cardiac troponin T, BNP Brain natriuretic peptide, eGFR estimated glomerular filtration rate, NYHA New York Heart Association functional class

ISSN: 1471-2261